Report Description Table of Contents Industry Report and Statistics (Facts & Figures) - Number of Test Conducted, Demand & Sales Analysis by Product & End-User The global DNA sequencing market will witness a robust CAGR of 17.12%, valued at $10.5 billion in 2021, expected to appreciate and reach $44 billion by 2030, confirms Strategic Market Research. In 2019, North America had the highest DNA sequencing market size, with 44.3% of its total revenue share. DNA sequencing is a laboratory method to determine the sequences of bases {adenine (A), cytosine (C), guanine (G) and thymine (T)} in a DNA molecule. A sample containing the DNA to be sequenced is prepared. The target sequence is then amplified using polymerase chain reaction (PCR). The amplicons obtained are then purified thoroughly, followed by preparations for the sequencing of the DNA. The DNA is then sequenced to obtain the required data, which is then analyzed thoroughly. It has been declared by the National Human Genome Research Institute (NHGRI) that all human beings are 99.9% identical in their genetic makeup. The remaining 0.1% is studied using DNA sequencing to determine the causes of the diseases. This technique has extensive applications in molecular biology, evolutionary biology, metagenomics, virology, medicine, and forensic investigations. Market Drivers Government programs that support genomics research, precision medicine initiatives, and genomic project funding have significantly boosted the market for DNA sequencing. Investments in research infrastructure, genomic data repositories, and large-scale sequencing programs promote technological innovation and market expansion. Genomic research is heavily funded by government organizations, such as the National Institutes of Health. NHGRI has set an ambitious goal to make genome sequencing a standard diagnostic tool in healthcare for $1,000 or less, which is 10,000 times less expensive than present technology. Doctors will be able to diagnose, treat, and eventually prevent many common diseases like cancer, heart disease, diabetes, and obesity by customizing medical therapies based on a patient's genetic profile, thanks to the lower costs. Advancements like fluorescent dyes, radioactive molecules for DNA sequencing, and polymerase chain reaction (PCR) for amplification made it feasible to sequence thousands of base pairs in just a few hours. DNA sequencing has revolutionized because of next-generation sequencing technologies, which allow for quicker and more economical analysis. NGS techniques use a variety of strategies, each with specific benefits and drawbacks, including Illumina, Ion Torrent, and Pacific Biosciences sequencing. For example, reversible terminators and fluorescently tagged nucleotides are used in Illumina sequencing to concurrently produce millions of short DNA fragments. Therefore, advancement in next generation sequencing is significantly boosting the demand for DNA sequencing. Market Restraints The high cost of sequencing technologies and services is a major barrier to the DNA sequencing market. The financial burden is further increased by continuing operating costs for things like consumables, reagents, and specialized labor. Furthermore, Ethical issues related to genetic information misuse and privacy must be considered carefully. While data security remains a top priority, reimbursement policies and legislation are subject to change, making it more complex. As technology develops, DNA sequencing is becoming more useful and accessible, overcoming previous obstacles. Market Opportunities - Advancement in DNA sequencing techniques has opened up vast growth opportunities for the market in the future DNA sequencing has undergone remarkable advancements in recent years, transforming various areas of scientific research and medical diagnosis. Organizations like the Cooperative Center for DNA Sequencing and Bioinformatics (CCDB) have played a crucial role in the recent breakthroughs in genomics. CCDB's advanced technologies and expertise in DNA sequencing have helped scientists uncover the mysteries of genomics, paving the way for further research. CCDB has played a significant role in advancing single-molecule sequencing methods. Unlike conventional techniques that require amplification of DNA samples, single-molecule sequencing reads individual DNA molecules directly. This method eliminates biases induced by amplification and generates a more precise representation of the genome. For example, the CCDB-supported SMRT (Single-Molecule Real-Time) sequencing technique from Pacific Biosciences allows for highly accurate long-read sequencing, which makes it easier to analyze complicated genomic areas in detail. Thus, advancement in DNA sequencing techniques has opened up vast growth opportunities for the market in the future. Market Analysis Of Different Segments Covered in the Report Based on Product Consumables Instruments Services Based on Technology Sanger Sequencing Next-Generation Sequencing (NGS) Whole Genome Sequencing (WGS) Whole Exome Sequencing (WES) Targeted Sequencing and Resequencing Third Generation DNA Sequencing Single-Molecule Real-Time Sequencing (SMRT) Nanopore Sequencing Based on Workflow Pre-sequencing Sequencing Data Analysis Based on Application Oncology Reproductive health Clinical Investigation Agri genomics and Forensics HLA Typing/Immune System Monitoring Metagenomics, Epidemiology and Drug Development Consumer Genomics Others Based on End-Use Academic Research Clinical Research Hospitals and Clinics Pharmaceutical and Biotechnology Companies Other Users Regional Coverage Analysis North America United States of America Canada Mexico Rest of North America Europe Germany United Kingdom France Italy Spain Rest of Europe Asia-Pacific China Japan India Rest of APAC LAMEA Brazil Argentina UAE Rest of LAMEA Segments Analysis & Insights Based on product, Consumables held the largest DNA sequencing market share of 43% in 2019. The widespread adoption of DNA sequencing procedures is motivated by the need for efficient, cost-effective, standardized, high-quality, and flexible consumables. DNA sequencing heavily relies on consumables such as enzymes, specialized tubes, and pre-made kits. These consumables play a crucial role in the overall cost of sequencing. A study published in Nature Genetics in 2021 revealed that consumables can account for 60-80% of the total sequencing costs. Based on technology, the Next-Generation Sequencing (NGS) segment held the largest market share of 58.6% in 2019.Advancements in next-generation sequencing have enabled affordable and rapid sequencing of whole transcriptomes or genomes, leading to progress in drug discovery, infectious disease surveillance, and cancer research. DNA sequencing, for example, has proved useful in detecting genetic alterations that fuel the spread of cancer and has facilitated the creation of targeted medicines such as Herceptin. Based on workflow, the Sequencing segment held the maximum revenue share of 52.9% in 2019. The largest share of this segment is because of its ability to read DNA with high efficiency and accuracy. Based on application, the Oncology segment comprehensively dominated the market for DNA sequencing with a share of 24.4% in 2019. DNA sequencing has revolutionized cancer research and treatment by identifying the genetic changes causing tumor growth. Scientists can examine the DNA of cancer cells using methods such as next-generation sequencing (NGS) to find certain mutations, gene fusions, or chromosomal abnormalities. For example, DNA sequencing can detect mutations in genes such as EGFR or ALK in patients with non-small cell lung cancer (NSCLC). These alterations suggest that targeted medicines, like tyrosine kinase inhibitors, may be more successful than conventional chemotherapy in providing a more focused and efficient treatment. Based on end-use, the academic research segment dominated the market with a revenue share of 55.4% in 2019 due to the increased acceptance and usage of Sanger technology and NGS in academic and institutional research projects. Based on Region, North America has dominated significantly with a market revenue share of 44.3% in 2019. This is due to the region's high cancer rates and favorable regulatory environment. Additionally, the area's advanced healthcare system, high disposable income, and public awareness of new sequencing techniques and initiatives are all factors that are likely to drive growth in the DNA sequencing market in this region. The rising incidence of cancer in the US is one of the main factors driving North America's DNA sequencing market growth. For example, the American Cancer Society projects that 287,850 new instances of invasive breast cancer in women in the US were detected in 2022. Thus, it is anticipated that the rising prevalence of diseases like breast cancer in the nation will increase demand for DNA sequencing, including next-generation sequencing, for tumor analysis and prognostic biomarker identification. This will support the expansion of the DNA sequencing markets in the United States and North America. DNA Sequencing Market Report Coverage Report Attribute Details Forecast Period 2021 - 2030 Market size value in 2021 USD 10.5 billion Revenue forecast in 2030 USD 44 billion Growth rate CAGR of 17.12% The base year for estimation 2021 Historical data 2017 – 2020 Unit USD Billion, CAGR (2021 - 2030) Segmentation By product, By technology, By workflow, by application, By end-use and By region. By Product Consumables, Instruments, Services By Technology Sanger Sequencing, Next-Generation Sequencing (NGS), Third Generation DNA Sequencing By Workflow Pre-sequencing, Sequencing, Data Analysis By Application Oncology, Reproductive health, Clinical Investigation, Agri genomics and Forensics, HLA Typing/Immune System Monitoring, Metagenomics, Epidemiology and Drug Development, Consumer Genomics, Others By End-Use Academic Research, Clinical Research, Hospitals and Clinics, Pharmaceutical and Biotechnology Companies, Other Users By Region Asia Pacific, North America, Europe, and LAMEA Country Scope US, Mexico, Canada, Germany, UK, France, China, Japan, India etc. Company Usability Profiles Merck KGaA, Thermo Fischer Scientific, Inc., Agilent Technologies, Inc., Illumina, Inc., F. Hoffman-La Roche Ltd., Siemens Healthineers AG, Pacific Biosciences, Eppendorf, OpenTrons, Gilson, Neotec, TTP Labtech Ltd., Beckman Coulter, Element Biosciences, Inc. Pricing and purchase options Customized buying options are available to meet your exact research needs. Global DNA Sequencing Market Competitive Landscape Analysis The market is very competitive and has a few significant players. These companies make substantial efforts to address consumer demand. They make substantial investments in production, distribution, and total quality management for their portfolio expansion. The key players in this market are: Merck KGaA Thermo Fischer Scientific, Inc. Agilent Technologies, Inc. Illumina, Inc. F. Hoffman-La Roche Ltd. Siemens Healthineers AG Pacific Biosciences Eppendorf OpenTrons Gilson Neotec TTP Labtech Ltd. Beckman Coulter Element Biosciences, Inc. Recent Developments In January 2024, Quest Diagnostics, a leading provider of diagnostic information services, partnered with Ultima Genomics to utilize their next-generation sequencing technology in oncology and other clinical areas. The partnership seeks to expand the use of highly accurate, economical, and high-volume whole genome sequencing for fast-growing fields like solid-tumor minimal residual disease (MRD) diagnostics, thus improving patient access, affordability, and outcomes. In addition to its current whole exome sequencing approach, Quest plans to use the Ultima technology for future whole genome testing applications, such as detecting rare diseases in pediatric patients. They also plan to use the technology for potential lab-developed tests involving its Haystack solid-tumor MRDTM technology for future clinical and biopharmaceutical MRD applications. In February 2024, Ultima Genomics, a Leading participant in the genomics market, announced the release of its high-end DNA sequencers, which can read a human genome for as little as $100. This advancement has the potential to completely transform genomics by lowering the cost and increasing accessibility for scientists, medical professionals, and the general public. In March 2024, Nucleus Genomics, a next-generation genetic testing and analysis company, has recently launched its DNA analysis solution. This solution allows individuals to benefit from personalized medicine by providing insights into how their DNA might impact their health. Although fundamental insights into the relationship between DNA and health are lacking in healthcare, Nucleus Genomics provides a platform for consumers to upload their DNA data from previous microarray genetic testing with other businesses. The platform analyzes the data to determine the consumer's genetic susceptibility to various diseases, including breast cancer and type 2 diabetes. Additionally, Nucleus Genomics uses lifestyle and personal parameters such as age, blood pressure, cholesterol, and BMI to further customize user risk evaluations. Various Leading DNA Sequencing Devices that Key Market Leaders Develop Name of the Product Function Company OpenTrons OT-2 Pipetting for genomics, proteomics, cell-based assays and drug discovery OpenTrons Gilson Pipetmax Pipetting for biological assays Gilson Neotec EzMate Pipetting for PCR/ qPCR sample preparation Neotec TTP Labtech Mosquito HV Genomics Pipetting for miniaturised molecular biology TTP Labtech Ltd. Beckman Coulter Labcyte Echo 525 Biochemical and Genomics Reagent Transfer Beckman Coulter Frequently Asked Question About This Report What are the key drivers to the growth of the market? The major factors that contribute to the growth of the market are technological advancements in DNA sequencing and increasing applications in clinical diagnosis and drug discovery. Which segment holds the maximum share in the market based on technology? The Next-Generation Sequencing segment held the highest share in the market based on technology, with a revenue share of 58.6% in 2019. Which segment holds the highest share in the market based on application? The oncology segment held the maximum revenue share in the market, with a share of 24.4% in 2019. Which segment holds the most significant revenue share in the market based on region? The North American region held the most significant revenue share in the market, with a revenue contribution of 44.3% in 2019. What are the DNA sequencing market growth? The global DNA sequencing market is expected to grow at a compound annual growth rate (CAGR) of 17.12 % from 2021 to 2030 to reach USD 44 Billion by 2030. How big is the DNA sequencing market? The global DNA sequencing market size was $ 10.5 Bn in 2021 and is predicted to reach $ 44 Bn by 2030, with a CAGR of 17.12 %. Sources https://www.genome.gov/17516714/2006-release-about-whole-genome-association-studies https://rarediseases.org/wp-content/uploads/2019/01/RDD-FAQ-2019.pdf https://www.genome.gov/about-genomics/fact-sheets/Sequencing-Human-Genome-cost https://ascpt.onlinelibrary.wiley.com/doi/full/10.1111/cts.12980 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6161442/ https://sapac.illumina.com/science/technology/next-generation-sequencing/beginners/ngs-cost.html c1. Introduction 1.1. Study Objective 1.2. market Definition 1.3. Study Scope 1.3.1. markets Covered 1.3.2. Geographic Scope 1.3.3. Years Considered 1.3.4. Stakeholders 2. Research Methodology 2.1. Data Procurement 2.2. Paid Database 2.2.1. Secondary Data 2.2.1.1. Key Secondary sources 2.2.2. Primary Data 2.2.2.1 Primary sources 2.2.2.2. Key industry insights 2.2.2.3. Primary interviews with experts 2.2.2.4. Key primary respondent list 2.3. market Size Estimation 2.4. Bottom-Up and Top-Down Approaches 2.4.1. Bottom-Up Approach 2.4.1.1. Approach for arriving at market size by bottom-up analysis 2.4.2. Top-Down Approach 2.4.2.1. Approach for Capturing market Size by Top-Down Analysis 2.5. market Breakdown and Data Triangulation 2.6. Research Methodology 2.7. Risk Assessment 3. Executive Summary 3.1 DNA Sequencing market: Post-Covid-19 3.1.1 Actual Scenario 3.1.2 Pessimistic Scenario 3.1.3 Optimistic Scenario 3.1.4 market Summary 4. Industry Outlook 4.1 market Snapshot 4.2 Global DNA Sequencing market 4.2.1 Global DNA Sequencing market, 2021 – 2028 (USD Million) 4.3 Regional Business Analysis 4.3.1 Global DNA Sequencing market, by Region, 2021 - 2030 (USD Million) 4.4 By Product Business Analysis 4.4.1 Global DNA Sequencing market, By Product, 2021 - 2030 (USD Million) 4.5 By Technology Business Analysis 4.5.1 Global DNA Sequencing market, By Technology, 2021 - 2030 (USD Million) 4.6 By Workflow Business Analysis 4.6.1 Global DNA Sequencing market, By Workflow, 2021 - 2030 (USD Million) 4.7 By End-User Business Analysis 4.7.1 Global DNA Sequencing market, By End-User, 2021 - 2030 (USD Million) 4.8 ApplicationBusiness Analysis 4.8.1 Global DNA Sequencing market, By Application, 2021 - 2030 (USD Million) 4.9 Value Chain Analysis 4.10 market Variable Analysis 4.10.1 market Drivers Analysis 4.10.2 market Restraints Analysis 4.11 Business Environment Analysis Tool 4.11.1 DNA Sequencing market PEST analysis 4.11.2 DNA Sequencing market Porter’s analysis 4.12 Penetration & Growth Prospect Mapping 5. market Dynamics 5.1. Introduction 5.2. market Dynamics 5.2.1. Drivers 5.2.2. Restraints 5.2.3. Opportunities 5.2.4. Challenges 5.3. Impact of Covid-19 On DNA Sequencing market 5.4. Value Chain Analysis 5.5. Ecosystem 5.6. Patent Analysis 5.7. Trade Analysis 5.8. Tariff Analysis 5.9. Case Study Analysis 5.10. Porter’s Five Forces Analysis 5.10.1 Threat of New Entrants 5.10.2 Threat of Substitutes 5.10.3 Bargaining Power of Buyers 5.10.4 Bargaining Power of Suppliers 5.10.5 Degree of Competition 5.11. Technology Analysis 5.11.1. Trends in Technology (2014-2021) 5.11.2. Trends in Technology (2021-2028) 5.12. Pricing Analysis 5.12.1. Average Price Trend Analysis (By region, By Countries) 6. Competitive & Vendor Landscape 6.1. Company market Share Analysis 6.2. Manufacturers DNA Sequencing Manufacturing Sites, Area Served, Product Type 6.3. DNA Sequencing market Competitive Situation and Trends 6.4. Manufacturers Mergers & Acquisitions, Expansion Plans 7. Global DNA Sequencing market: By Product Segment Analysis 7.1. Introduction 7.2. Sales Volume & Revenue Analysis (2021-2030) 7.3. Consumables 7.3.1. Consumables market, 2021 - 2030 (USD Million) 7.4. Instruments 7.4.1. Instruments market, 2021 - 2030 (USD Million) 7.5. Services 7.5.1 Services market, 2021 - 2030 (USD Million) 8. Global DNA Sequencing market: By Technology Segment Analysis 8.1. Introduction 8.2. Sales Volume & Revenue Analysis (2021-2030) 8.3. Sanger Sequencing 8.3.1. Sanger Sequencing market, 2021 - 2030 (USD Million) 8.4. Next-Generation Sequencing (NGS) 8.4.1. Next-Generation Sequencing (NGS) market, 2021 - 2030 (USD Million) 8.4.1.1 Whole Genome Sequencing (WGS) market, 2021 - 2030 (USD Million) 8.4.1.2 Whole Exome Sequencing (WES) market, 2021 - 2030 (USD Million) 8.4.1.3 Targeted Sequencing and Resequencing 8.5 Third Generation DNA Sequencing 8.5.1 Third Generation DNA Sequencing market, 2021 - 2030 (USD Million) 8.5.1 Single-Molecule Real-Time Sequencing (SMRT) market, 2021 - 2030 (USD Million) 8.5.1 Nanopore Sequencing market, 2021 - 2030 (USD Million) 9. Global DNA Sequencing market: By Workflow Segment Analysis 9.1. Introduction 9.2. Sales Volume & Revenue Analysis (2021-2030) 9.3. Pre-sequencing 9.3.1. Pre-sequencing market, 2021 - 2030 (USD Million) 9.4. Sequencing 9.4.1. Sequencing market, 2021 - 2030 (USD Million) 9.5 Data Analysis 9.5.1 Data Analysis market, 2021 - 2030 (USD Million) 10. Global DNA Sequencing market: By End-User Segment Analysis 10.1. Introduction 10.2. Sales Volume & Revenue Analysis (2021-2030) 10.3. Academic Research 10.3.1. Academic Research market, 2021 - 2030 (USD Million) 10.4. Clinical Research 10.4.1. Clinical Research market, 2021 - 2030 (USD Million) 10.5 Hospitals and Clinics 10.5.1 Hospitals and Clinics market, 2021 - 2030 (USD Million) 10.6 Pharmaceutical and Biotechnology Companies 10.6.1 Pharmaceutical and Biotechnology Companies market, 2021 - 2030 (USD Million) 10.7 Others Users 10.7.1 Others Users market, 2021 - 2030 (USD Million) 11. Global DNA Sequencing market: By Application Segment Analysis 11.1. Introduction 11.2. Sales Volume & Revenue Analysis (2021-2030) 11.3. Oncology 11.3.1. Oncology market, 2021 - 2030 (USD Million) 11.4.Reproductive health 11.4.1. Reproductive health market, 2021 - 2030 (USD Million) 11.5 Clinical Investigation 11.5.1 Clinical Investigation market, 2021 - 2030 (USD Million) 11.6 Agri genomics and Forensics 11.6.1 Agri genomics and Forensics market, 2021 - 2030 (USD Million) 11.7 HLA Typing/Immune System Monitoring 11.7.1 HLA Typing/Immune System Monitoring market, 2021 - 2030 (USD Million) 11.8 Metagenomics, Epidemiology and Drug Development 11.8.1 Metagenomics, Epidemiology and Drug Development market, 2021 - 2030 (USD Million) 11.9 Consumer Genomics 11.9.1 Consumer Genomics market, 2021 - 2030 (USD Million) 12. Global DNA Sequencing market: Region 12.1 North America 12.1.1. North America DNA Sequencing market, By End-User, 2021 - 2030 (USD Million) 12.1.4. North America DNA Sequencing market, By Application, 2021 - 2030 (USD Million) 12.1.5. North America DNA Sequencing market, by Country, 2021 - 2030 (USD Million) 12.1.4.1. U.S. 12.1.4.1.1. U.S. DNA Sequencing market, By End-User, 2021 - 2030 (USD Million) 12.1.4.2. Canada 12.1.4.2.1. Canada DNA Sequencing market, By End-User, 2021 - 2030 (USD Million) 12.1.4.2.2. Canada DNA Sequencing market, By Region, 2021 - 2030 (USD Million) 12.1.4.2.3. Canada DNA Sequencing market, by Applications, 2021 - 2030 (USD Million) 12.2. Europe 12.2.1. Europe DNA Sequencing market, By End-User, 2021 - 2030 (USD Million) 12.2.2. Europe DNA Sequencing market, by By Application, 2021 - 2030 (USD Million) 12.2.5. Europe DNA Sequencing market, by country, 2021 - 2030 (USD Million) 12.2.4.1 U.K. 12.2.4.1.1. U.K. DNA Sequencing market, By End-User, 2021 - 2030 (USD Million) 12.2.4.1.2. U.K. DNA Sequencing market, By Applications, 2021 - 2030 (USD Million) 12.2.4.1.3. U.K. DNA Sequencing market, by Region, 2021 - 2030 (USD Million) 12.2.4.2. Germany 12.2.4.2.1. Germany DNA Sequencing market, By End-User, 2021 - 2030 (USD Million) 12.2.4.2.2. Germany DNA Sequencing market, By Application, 2021 - 2030 (USD Million) 12.2.4.2.3. Germany DNA Sequencing market, by Region, 2021 - 2030 (USD Million) 12.2.4.3. France 12.2.4.3.1. France DNA Sequencing market, By End-User, 2021 - 2030 (USD Million) 12.2.4.3.2. France DNA Sequencing market, By Region, 2021 - 2030 (USD Million) 12.2.4.3.3. France DNA Sequencing market, by Application, 2021 - 2030 (USD Million) 12.2.4.4. Rest of Europe 12.2.4.4.1. Rest of Europe DNA Sequencing market, By End-User, 2021 - 2030 (USD Million) 12.2.4.4.2. Rest of Europe DNA Sequencing market, By Region, 2021 - 2030 (USD Million) 12.2.4.4.3. Rest of Europe DNA Sequencing market, by Application, 2021 - 2030 (USD Million) 12.3. Asia Pacific 12.3.1. Asia Pacific DNA Sequencing market, By End-User, 2021 - 2030 (USD Million) 12.3.2. Asia Pacific DNA Sequencing market, By Application, 2021 - 2030 (USD Million) 12.3.5. Asia Pacific DNA Sequencing market, by country, 2021 - 2030 (USD Million) 12.3.4.1. China 12.3.4.1.1. China DNA Sequencing market, By End-User, 2021 - 2030 (USD Million) 12.3.4.1.2. China DNA Sequencing market, By Region, 2021 - 2030 (USD Million) 12.3.4.1.3. China DNA Sequencing market, by Application, 2021 - 2030 (USD Million) 12.3.4.2. India 12.3.4.2.1. India DNA Sequencing market, By End-User, 2021 - 2030 (USD Million) 12.3.4.2.2. India DNA Sequencing market, By Region, 2021 - 2030 (USD Million) 12.3.4.2.3. India DNA Sequencing market, by Application, 2021 - 2030 (USD Million) 12.3.4.3. Japan 12.3.4.3.1. JapanDNA Sequencing market, By End-User, 2021 - 2030 (USD Million) 12.3.4.3.3. Japan DNA Sequencing market, by Application, 2021 - 2030 (USD Million) 12.3.4.4. South Korea 12.3.4.4.1. South Korea DNA Sequencing market, By End-User, 2021 - 2030 (USD Million) 12.3.4.4.3. South Korea DNA Sequencing market, by Application, 2021 - 2030 (USD Million) 12.3.4.5. Rest of ASIA PACIFIC 12.3.4.5.1. Rest of ASIA PACIFICDNA Sequencing market, By End-User, 2021 - 2030 (USD Million) 12.3.4.5.3. Rest of ASIA PACIFICDNA Sequencing market, by Application, 2021 - 2030 (USD Million) 12.4. Latin America 12.4.1. Latin America DNA Sequencing market, By End-User, 2021 - 2030 (USD Million) 12.4.3. Latin America DNA Sequencing market, by Application, 2021 - 2030 (USD Million) 12.4.4. Latin America DNA Sequencing market, by country, 2021 - 2030 (USD Million) 12.4.4.1. Brazil 12.4.4.1.1. Brazil DNA Sequencing market, By End-User, 2021 - 2030 (USD Million) 12.4.4.1.3. Brazil DNA Sequencing market, by Application, 2021 - 2030 (USD Million) 12.4.4.2. Mexico 12.4.4.2.1. Mexico DNA Sequencing market, By End-User, 2021 - 2030 (USD Million) 12.4.4.2.3. Mexico DNA Sequencing market, by Application, 2021 - 2030 (USD Million) 12.4.4.3. Rest of the Latin America 12.4.4.3.1. Rest of the Latin AmericaDNA Sequencing market, By End-User, 2021 - 2030 (USD Million) 12.4.4.3.3. Rest of the Latin AmericaDNA Sequencing market, by Application, 2021 - 2030 (USD Million) 13. Competitive Landscape 13.1 Merck KGaA 13.1.1. Company overview 13.1.2. Financial performance 13.1.3. Product Portfolio Analysis 13.1.4. Business Strategy & Recent Development 13.2. Thermo Fischer Scientific, Inc. 13.2.1. Company overview 13.2.2. Financial performance 13.2.3. Product Portfolio Analysis 13.2.4. Business Strategy & Recent Development 13.3. Agilent Technologies, Inc. 13.3.1. Company overview 13.3.2. Financial performance 13.3.3. Product Portfolio Analysis 13.3.4. Business Strategy & Recent Development 13.4. Illumina, Inc. 13.4.1. Company overview 13.4.2. Financial performance 13.4.3. Product Portfolio Analysis 13.4.4. Business Strategy & Recent Development 13.5. F. Hoffman-La Roche Ltd. 13.5.1. Company overview 13.5.2. Financial performance 13.5.3. Product Portfolio Analysis 13.5.4. Business Strategy & Recent Development 13.6. Siemens AG. 13.6.1. Company overview 13.6.2. Financial performance 13.6.3. Product Portfolio Analysis 13.6.4. Business Strategy & Recent Development 13.7. Pacific Biosciences. 13.7.1. Company overview 13.7.2. Financial performance 13.7.3. Product Portfolio Analysis 13.7.4. Business Strategy & Recent Development 13.8. Eppendorf. 13.8.1. Company overview 13.8.2. Financial performance 13.8.3. Product Portfolio Analysis 13.8.4. Business Strategy & Recent Development List of Tables (52 Tables) TABLE 1. DNA Sequencing market, By Product, 2021-2030 (USD Million) TABLE 2. DNA Sequencing market FOR Consumables, BY REGION, 2021-2030 (USD Million) TABLE 3. DNA Sequencing market FOR Instruments, BY REGION, 2021-2030 (USD Million) TABLE 4. DNA Sequencing market FOR Services, BY REGION, 2021-2030 (USD Million) TABLE 5. DNA Sequencing market FOR Software, BY REGION, 2021-2030 (USD Million) TABLE 6. DNA Sequencing market, By Technology, 2021-2030 (USD Million) TABLE 7. DNA Sequencing market FOR Sanger Sequencing, BY REGION, 2021-2030 (USD Million) TABLE 8. DNA Sequencing market FOR Next-Generation Sequencing (NGS), BY REGION, 2021-2030 (USD Million) TABLE 9. DNA Sequencing market FOR Third Generation DNA Sequencing, BY REGION, 2021-2030 (USD Million) TABLE 10. DNA Sequencing market FOR Hospitals and Clinics, BY REGION, 2021-2030 (USD Million) TABLE 11. DNA Sequencing market, By Workflow, 2021-2030 (USD Million) TABLE 12. DNA Sequencing market FOR Pre-sequencing, BY REGION, 2021-2030 (USD Million) TABLE 13. DNA Sequencing market FOR Sequencing, BY REGION, 2021-2030 (USD Million) TABLE 14. DNA Sequencing market FOR Data Analysis, BY REGION, 2021-2030 (USD Million) TABLE 15. DNA Sequencing market, By End-User, 2021-2030 (USD Million) TABLE 16. DNA Sequencing market FOR Academic Research, BY REGION, 2021-2030 (USD Million) TABLE 17. DNA Sequencing market FOR Clinical Research, BY REGION, 2021-2030 (USD Million) TABLE 18. DNA Sequencing market FOR Hospitals and Clinics, BY REGION, 2021-2030 (USD Million) TABLE 19. DNA Sequencing market, BY APPLICATION, 2021-2030 (USD Million) TABLE 20. DNA Sequencing market FOR Oncology, BY REGION, 2021-2030 (USD Million) TABLE 21. DNA Sequencing market FOR Reproductive health, BY REGION, 2021-2030 (USD Million) TABLE 22. DNA Sequencing market FOR Clinical Investigation, BY REGION, 2021-2030 (USD Million) TABLE 23. DNA Sequencing market, BY REGION, 2021-2030 (USD Million) TABLE 24. NORTH AMERICA DNA Sequencing market, BY COUNTRY, 2021-2030 (USD Million) TABLE 25. NORTH AMERICA DNA Sequencing market, BY Applications, 2021-2030 (USD Million) TABLE 26. NORTH AMERICA DNA Sequencing market, By End-User, 2021-2030 (USD Million) TABLE 27. NORTH AMERICA DNA Sequencing market, BY APPLICATION, 2021-2030 (USD Million) TABLE 28. EUROPE DNA Sequencing market, BY COUNTRY, 2021-2030 (USD Million) TABLE 29. EUROPE DNA Sequencing market, By End-User, 2021-2030 (USD Million) TABLE 30. EUROPE DNA Sequencing market, BY APPLICATION, 2021-2030 (USD Million) TABLE 31. ASIA-PACIFIC DNA Sequencing market, BY COUNTRY, 2021-2030 (USD Million) TABLE 32. ASIA-PACIFIC DNA Sequencing market, By End-User, 2021-2030 (USD Million) TABLE 33. ASIA-PACIFIC DNA Sequencing market, BY APPLICATION, 2021-2030 (USD Million) TABLE 34. LAMEA DNA Sequencing market, BY COUNTRY, 2021-2030 (USD Million) TABLE 35. LAMEA DNA Sequencing market, By End-User, 2021-2030 (USD Million) TABLE 36. LAMEA DNA Sequencing market, BY APPLICATION, 2021-2030 (USD Million) TABLE 37. Merck KGaA: COMPANY SNAPSHOT TABLE 38. Merck KGaA: OPERATING SEGMENTS TABLE 39. Thermo Fischer Scientific, Inc: COMPANY SNAPSHOT TABLE 40. Thermo Fischer Scientific, Inc: OPERATING SEGMENTS TABLE 41. Agilent Technologies, Inc: COMPANY SNAPSHOT TABLE 42. Agilent Technologies, Inc: OPERATING SEGMENTS TABLE 43. Illumina, Inc: COMPANY SNAPSHOT TABLE 44. Illumina, Inc: OPERATING SEGMENTS TABLE 45. F. Hoffman-La Roche Ltd: COMPANY SNAPSHOT TABLE 46. F. Hoffman-La Roche Ltd: OPERATING SEGMENTS TABLE 47. Siemens AG: COMPANY SNAPSHOT TABLE 48. Siemens AG: OPERATING SEGMENTS TABLE 49. Pacific Biosciences: COMPANY SNAPSHOT TABLE 50. Pacific Biosciences: OPERATING SEGMENTS TABLE 51. Eppendorf: COMPANY SNAPSHOT TABLE 52. Eppendorf: OPERATING SEGMENTS List of Figures (26 Figures) Figure 1 DNA Sequencing market: Research Methodology Steps Figure 2 Research Design Figure 3 Breakdown of Primaries: DNA Sequencing market Figure 4 Research Methodology: Hypothesis Building Figure 5 DNA Sequencing market: Application-Based Estimation Figure 6 Top 8 Companies with Highest No. Of Patent in Last 9 Years Figure 7 No. Of Patents Granted Per Year, 2019–2021 Figure 8 Import Data for DNA Sequencing, By Country, 2016–2021 (USD Thousand) Figure 9 Export Data for DNA Sequencing, By Country, 2016–2021 (USD Thousand) Figure 10 Data Triangulation Methodology Figure 11 DNA Sequencing market, By Product, 2019 vs. 2025 (USD Million) Figure 12 DNA Sequencing market, By Technology, 2019 vs. 2025 (USD Million) Figure 13 DNA Sequencing market, By Workflow, 2019 vs. 2025 (USD Million) Figure 14 DNA Sequencing market, By End-User, 2019 vs. 2025 (USD Million) Figure 15 DNA Sequencing market Share, By Application Type, 2019 vs. 2025 Figure 16 Geographical Snapshot of the DNA Sequencing market Figure 17 Consumables to Witness Higher CAGR in DNA Sequencing market for Product Segment during Forecast Period. Figure 18 Next-Generation DNA Sequencing to Witness Higher CAGR in DNA Sequencing market for Technology Segment during Forecast Period. Figure 19 Sequencing segment to Witness Higher CAGR in DNA Sequencing market for Workflow Segment during Forecast Period. Figure 20 Academic research to Witness Higher CAGR in DNA Sequencing market for End-User Segment during Forecast Period. Figure 21 Oncology segment to Witness Higher CAGR in DNA Sequencing market for Application Segment during Forecast Period. Figure 22 North America Accounted for the Largest Share of the DNA Sequencing market, By Regional Basis, in 2019 Figure 23 DNA Sequencing market: Drivers, Restraints, Opportunities, and Challenges Figure 24 North America: DNA Sequencing market Snapshot Figure 25 Asia Pacific: DNA Sequencing market Snapshot Figure 26 Vendor Dive: Evaluation Overview